Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

3.60USD
3:59pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.60
Open
$3.74
Day's High
$3.74
Day's Low
$3.46
Volume
6,083
Avg. Vol
22,380
52-wk High
$5.46
52-wk Low
$0.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.448
Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
FY 2016 Sep '16 0.00 -0.530
Jun '16 0.00 -0.746
Mar '16 0.00 -0.350
Dec 0.00 -0.532
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Sep-18 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Sep-18 1 -1.25 -1.25 -1.25 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.22 34.75
P/E High - Last 5 Yrs. -- 40.52 46.00
P/E Low - Last 5 Yrs. -- 23.42 24.22
Beta -- 0.82 0.81
Price to Sales (TTM) -- 5.89 8.23
Price to Book (MRQ) 1.37 4.39 5.26
Price to Tangible Book (MRQ) 31.57 4.88 6.43
Price to Cash Flow (TTM) -- 23.16 26.16
% Owned Institutions 2.38 1.24 2.26

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 2.16 2.02
Dividend 5 Year Growth Rate -- 4.22 5.22
Payout Ratio(TTM) -- 43.85 43.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.56 9.79
Sales (TTM) vs TTM 1 Yr. Ago -- 6.39 7.60
Sales - 5 Yr. Growth Rate -- 9.89 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.48 15.47 17.74
EPS (TTM) vs TTM 1 Yr. Ago 10.58 -- --
EPS - 5 Yr. Growth Rate -- 10.51 11.61
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.40 2.43
Current Ratio (MRQ) 1.39 3.35 3.39
LT Debt to Equity (MRQ) 0.00 9.22 12.05
Total Debt to Equity (MRQ) 0.79 12.44 15.44
Interest Coverage (TTM) -8.80 44.60 38.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.16 54.71
Gross Margin - 5 Yr. Avg. -- 52.53 52.58
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.45 14.67
Operating Margin (TTM) -- 11.74 4.61
Operating Margin - 5 Yr. Avg. -- 14.27 9.99
Pre-Tax Margin (TTM) -- 12.11 5.35
Pre-Tax Margin - 5 Yr. Avg. -- 14.54 10.27
Net Profit Margin (TTM) -- 8.53 1.86
Net Profit Margin - 5 Yr. Avg. -- 10.89 6.57
Effective Tax Rate (TTM) -- 22.27 21.98
Effective Tax Rate - 5 Yr. Avg. -- 23.56 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,805,544 828,235,197
Net Income/Employee (TTM) -- 108,709,740 96,880,046
Receivable Turnover (TTM) -- 5.32 5.42
Inventory Turnover (TTM) -- 2.61 3.50
Asset Turnover (TTM) 0.00 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.79 11.18 10.70
Return on Assets - 5 Yr. Avg. -- 12.69 12.05
Return on Investment (TTM) -53.65 14.09 13.63
Return on Investment - 5 Yr. Avg. -- 16.61 15.78
Return on Equity (TTM) -53.65 15.56 15.25
Return on Equity - 5 Yr. Avg. -- 17.70 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 17.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.38%
# of Holders: 7
Total Shares Held: 237,736
3 Mo. Net Change: 202,269
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.